Pulmonx Corp
For the period ended Dec 31, 2024. Filed Feb 25, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 25, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
Insider Trading Arrangements
The following discussion includes trading arrangements adopted orterminated by our directors and officers during the three months ended December 31, 2024.
On November 18, 2024, David Lehman, our General Counsel, adopted a new Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 13,622 shares of our common stock. The trading arrangement will expire on November 18, 2025, or earlier if all transactions under the trading arrangement are completed or if the trading arrangement is otherwise terminated according to its terms.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.